SCHEMBL2763282

SCHEMBL2763282

COc1cccc2c1Sc1ccccc1CC2=O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.68
MEN1 O00255 5/20 0.68
ALDH1A1 P00352 5/20 0.58
HPGD P15428 3/20 0.58
KDM4E B2RXH2 3/20 0.58
L3MBTL1 Q9Y468 3/20 0.57
NPSR1 Q6W5P4 1/20 0.57
HTT P42858 1/20 0.49
ATM Q13315 1/20 0.49
MAPT P10636 2/20 0.46
LMNA P02545 1/20 0.46
GPR84 Q9NQS5 6/20 0.45
BLM P54132 1/20 0.43
BCHE P06276 1/20 0.41
CES1 P23141 1/20 0.41
GAA P10253 2/20 0.41
CASP3 P42574 1/20 0.41
CASP6 P55212 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13113715 0.81 KMT2A (1.00) KMT2AMEN1ALDH1A1HPGDKDM4E
SCHEMBL7112968 0.78 KMT2A (0.61) KMT2AMEN1ALDH1A1HPGDKDM4E
SCHEMBL2762987 0.78 MEN1 (0.54) KMT2AMEN1ALDH1A1HPGDKDM4E
SCHEMBL2762725 0.78 KMT2A (0.68) KMT2AMEN1ALDH1A1HPGDKDM4E
SCHEMBL2763156 0.75 CA12 (0.40) KMT2AMEN1ALDH1A1HPGDMAPT
SCHEMBL3749553 0.74 ALDH1A1 (1.00) KMT2AMEN1ALDH1A1HPGDKDM4E
SCHEMBL7110256 0.74 ALDH1A1 (0.59) KMT2AMEN1ALDH1A1HPGDKDM4E
SCHEMBL11480404 0.74 HPGD (0.59) KMT2AMEN1ALDH1A1HPGDKDM4E
SCHEMBL11488577 0.72 ALDH1A1 (0.59) KMT2AMEN1ALDH1A1HPGDKDM4E
SCHEMBL5640862 0.71 KMT2A (0.63) KMT2AMEN1ALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023284794-A1 ASYMMETRIC GPR84 ANTAGONIST AND USE THEREOF 中国科学院上海药物研究所 2023-01-19 WO disclosed
EP-3594221-B1 GPR84 RECEPTOR ANTAGONIST AND USE THEREOF SHANGHAI INST MATERIA MEDICA CAS (CN) 2021-06-30 EP disclosed
EP-1485377-B9 PYRANONES USEFUL AS ATM INHIBITORS KUDOS PHARM LTD (GB) 2010-10-06 EP disclosed
EP-1485377-B9 PYRANONES USEFUL AS ATM INHIBITORS KUDOS PHARM LTD (GB) 2010-10-06 EP disclosed
EP-2174939-A1 Pyranones useful as ATM inhibitors Kudos Pharmaceuticals Limited (GB) 2010-04-14 EP disclosed
EP-2174939-A1 Pyranones useful as ATM inhibitors Kudos Pharmaceuticals Limited (GB) 2010-04-14 EP disclosed
EP-1485377-B1 PYRANONES USEFUL AS ATM INHIBITORS KUDOS PHARM LTD (GB) 2009-12-09 EP disclosed
EP-1485377-B1 PYRANONES USEFUL AS ATM INHIBITORS KUDOS PHARM LTD (GB) 2009-12-09 EP disclosed
US-7049313-B2 ATM inhibitors KUDOS PHARMACEUTICALS LTD. (GB) 2006-05-23 US disclosed
US-20040002492-A1 Induce immunology response; anticancer agents KUDOS PHARMACEUTICALS LTD (GB) 2004-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002492-A1 Induce immunology response; anticancer agents MYD88, IFNG, HCCS KMT2A 3178/4885MEN1 3307/4885ALDH1A1 3856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.